• Bacterial Culture, Upper Respiratory
  • Multiple myeloma
  • Tubulin receptor (Tubulin) Antibody, IgG
  • Dopamine D1 receptor (DRD1) Antibody, IgG
  • Lipoprotein Associated Phospholipase A2 Activity
  • Nudix Hydrolase 15 (NUDT15) Gene Mutation Analysis
  • Topiramate, Urine
  • BLM Gene (Bloom’s Syndrome) Mutation Analysis
  • Post-transplant Rejection Assessment, Kidney, Heart, Lung (Prospera™, AlloSure®, VitaGraft™/GraftAssureDx)
  • Zolpidem, Urine
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Oncotype DX, Breast Ductal Carcinoma in Situ (DCIS)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Oncotype DX, Breast Ductal Carcinoma in Situ (DCIS)
Medical Test

Reference Ranges
Access to Oncotype DX, Breast Ductal Carcinoma in Situ (DCIS) is restricted.
Loading...